DIA Biosimilars 2013

Articles Published in 2010

MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm

Wednesday, February 10, 2010 12:33 PM

MDS announced today plans to divide MDS Pharma Services, the company’s early-stage contract research organization (CRO), and sell it off to two separate companies for undisclosed amounts. The sale transactions are expected to close by April.

More... »

Cenduit: Now with Patient Reminders

Clinilabs Partners with Renal Research Institute

Wednesday, February 10, 2010 07:12 AM

New York-based contract research organization (CRO) Clinilabs recently announced a collaboration with the Renal Research Institute (also headquartered in New York) to conduct studies in patients with renal impairment.

More... »

CRF Health – eCOA Forum

PPD Profits Fall Short in 2009

Tuesday, February 9, 2010 06:59 AM

PPD’s full-year income from operations fell 32% in 2009, the contract research organization (CRO) reported last night. Revenues for the year were also down from $1.55 billion in 2008 to $1.42 billion.

More... »

Palm Beach Research Benefits from Close of Radiant West Palm Beach

Monday, February 8, 2010 07:01 AM

One investigative site’s bad fortune will become another site’s good as site management organization (SMO) Radiant Research closes its West Palm Beach, Fla., site, and Palm Beach Research Center takes on that site’s lead investigator along with an ongoing trial.

More... »

’09 Acquisitions Bring Phase Forward Revenues Up, Profits Down

Friday, February 5, 2010 10:19 AM

Phase Forward’s fourth quarter revenues jumped 22% but profits went down, the company reported Thursday night. Phase Forward’s share price was down 26.7% to $10.88 in early morning trading.

More... »

Clinilabs Launches New Document Management System

Thursday, February 4, 2010 07:02 AM

New York-based contract research organization (CRO) Clinilabs released its own document management system that the company said will significantly reduce the cost of information management and clinical monitoring and auditing during clinical trials.

More... »

FDA Issues Draft Guidance for IRBs Conducting Continuing Review

Wednesday, February 3, 2010 07:07 AM

The U.S. Food and Drug Administration (FDA) recently released draft guidance for institutional review board (IRB) continuing review—the first updates that the regulatory agency has provided for this process since it issued IRB regulations in 1981. 

More... »

Quintiles Partners with Belgium Pharma Movetis in Commercialization Deal

Tuesday, February 2, 2010 06:50 AM

Quintiles has entered into a strategic alliance with Movetis to help sell the Belgium pharma company’s new gastrointestinal product.

More... »

CenterWatch Monthly February 2010

Monday, February 1, 2010 07:57 AM

Second Wave of Sponsor, CRO Growth Hitting Asia-Pac

More... »

PRA Partners with Oncopartners in Brazil

Friday, January 29, 2010 07:57 AM

In an effort to speed up oncology trials in Latin America, PRA International entered into a partnership agreement with Oncopartners, a Latin American oncology development company, and its exclusive partner IBPC, a non-profit oncology research network made up of Brazil’s largest public oncology hospitals.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs